Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	RANBP2 ARHGAP24 GBP5 ARHGAP26 GPS2 ARHGAP29 GBP3 FGD6 SPATA13	5.32e-05	507	68	9	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	RANBP2 ARHGAP24 GBP5 ARHGAP26 GPS2 ARHGAP29 GBP3 FGD6 SPATA13	5.32e-05	507	68	9	GO:0030695
GeneOntologyMolecularFunction	cytoskeletal protein binding	CACNA1D BIN1 KIF23 ALMS1 BRCA2 MYO7B SPTB SYNE2 GBP3 DCLK2 NEB DCTN1	3.03e-04	1099	68	12	GO:0008092
GeneOntologyCellularComponent	symbiont cell surface	GBP5 GBP3	2.88e-04	8	68	2	GO:0106139
GeneOntologyCellularComponent	other organism part	GBP5 GBP3	3.70e-04	9	68	2	GO:0044217
Domain	HnRNP-L/PTB	PTBP2 HNRNPL	1.26e-04	5	67	2	IPR006536
Domain	GBP_C	GBP5 GBP3	5.60e-04	10	67	2	PF02841
Domain	G_GB1_RHD3_dom	GBP5 GBP3	6.83e-04	11	67	2	IPR030386
Domain	Guanylate-bd_C	GBP5 GBP3	6.83e-04	11	67	2	IPR003191
Domain	GBP	GBP5 GBP3	6.83e-04	11	67	2	PF02263
Domain	Guanylate-bd_N	GBP5 GBP3	6.83e-04	11	67	2	IPR015894
Domain	G_GB1_RHD3	GBP5 GBP3	6.83e-04	11	67	2	PS51715
Domain	SH3	BIN1 MYO7B ARHGAP26 NEB SPATA13	1.07e-03	216	67	5	SM00326
Domain	SH3	BIN1 MYO7B ARHGAP26 NEB SPATA13	1.07e-03	216	67	5	PS50002
Domain	SH3_domain	BIN1 MYO7B ARHGAP26 NEB SPATA13	1.16e-03	220	67	5	IPR001452
Domain	RhoGAP	ARHGAP24 ARHGAP26 ARHGAP29	1.43e-03	62	67	3	SM00324
Domain	RhoGAP	ARHGAP24 ARHGAP26 ARHGAP29	1.50e-03	63	67	3	PF00620
Domain	RHOGAP	ARHGAP24 ARHGAP26 ARHGAP29	1.57e-03	64	67	3	PS50238
Domain	RhoGAP_dom	ARHGAP24 ARHGAP26 ARHGAP29	1.57e-03	64	67	3	IPR000198
Domain	-	ARHGAP24 ARHGAP26 ARHGAP29	1.57e-03	64	67	3	1.10.555.10
Domain	WHTH_DNA-bd_dom	CUL5 UBR1 PAX3 HSF2 RPA2	1.76e-03	242	67	5	IPR011991
Domain	-	RANBP2 ARHGAP24 MYO7B ARHGAP26 FGD6 SPATA13	2.76e-03	391	67	6	2.30.29.30
Domain	SH3_9	BIN1 ARHGAP26 NEB	2.77e-03	78	67	3	PF14604
Domain	SH3_1	BIN1 ARHGAP26 NEB SPATA13	2.86e-03	164	67	4	PF00018
Domain	Actinin_actin-bd_CS	SPTB SYNE2	3.06e-03	23	67	2	IPR001589
Domain	Spectrin	SPTB SYNE2	3.06e-03	23	67	2	PF00435
Domain	ACTININ_2	SPTB SYNE2	3.06e-03	23	67	2	PS00020
Domain	ACTININ_1	SPTB SYNE2	3.06e-03	23	67	2	PS00019
Domain	Rho_GTPase_activation_prot	ARHGAP24 ARHGAP26 ARHGAP29	3.90e-03	88	67	3	IPR008936
Domain	PH_dom-like	RANBP2 ARHGAP24 MYO7B ARHGAP26 FGD6 SPATA13	4.20e-03	426	67	6	IPR011993
Domain	FYVE	RUFY1 FGD6	4.84e-03	29	67	2	PF01363
Domain	FYVE	RUFY1 FGD6	4.84e-03	29	67	2	SM00064
Domain	Spectrin_repeat	SPTB SYNE2	4.84e-03	29	67	2	IPR002017
Domain	Spectrin/alpha-actinin	SPTB SYNE2	5.87e-03	32	67	2	IPR018159
Domain	SPEC	SPTB SYNE2	5.87e-03	32	67	2	SM00150
Domain	Znf_FYVE-rel	RUFY1 FGD6	6.60e-03	34	67	2	IPR017455
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	RANBP2 KIF23 RESF1 BRCA2 RBM33 PDS5A NCAPG2	3.69e-07	222	71	7	37071664
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	KIF23 RESF1 ALMS1 N4BP2 CARMIL1 PARP8 SYNE2 DCLK2 SIK3 FGD6 SPATA13	1.33e-06	861	71	11	36931259
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RANBP2 RESF1 ALMS1 BRCA2 N4BP2 SEC23IP RUFY1 DCTN1	2.24e-06	418	71	8	34709266
Pubmed	ETAA1 acts at stalled replication forks to maintain genome integrity.	BRCA2 FANCM RPA2	1.06e-05	21	71	3	27723720
Pubmed	Nuclear translocation of IGF-1R via p150(Glued) and an importin-β/RanBP2-dependent pathway in cancer cells.	RANBP2 DCTN1	1.23e-05	3	71	2	24909165
Pubmed	Role of Nesprin-2 and RanBP2 in BICD2-associated brain developmental disorders.	RANBP2 SYNE2	1.23e-05	3	71	2	36930595
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	RESF1 ALMS1 BRCA2 RBM33 GPS2	1.54e-05	152	71	5	38360978
Pubmed	Human immunodeficiency virus type 1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation.	CUL5 RPA2	2.46e-05	4	71	2	18596088
Pubmed	Phosphorylated RPA recruits PALB2 to stalled DNA replication forks to facilitate fork recovery.	BRCA2 RPA2	2.46e-05	4	71	2	25113031
Pubmed	Guanylate-binding protein-5 is involved in inflammasome activation by bacterial DNA but only the cooperation of multiple GBPs accounts for control of Brucella abortus infection.	GBP5 GBP3	2.46e-05	4	71	2	38404575
Pubmed	Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.	BRCA2 FANCM	2.46e-05	4	71	2	19737859
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	RANBP2 BIN1 KIF23 ARHGAP24 N4BP2 SYNE2 SEC23IP SIK3 DCTN1 SPATA13	2.53e-05	963	71	10	28671696
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ADAMTS12 RANBP2 GGNBP2 PTBP2 N4BP2 PARP8 SYNE2 SEC23IP CFAP210 NEB DCTN1 SPATA13	3.27e-05	1442	71	12	35575683
Pubmed	Interaction between BRCA2 and replication protein A is compromised by a cancer-predisposing mutation in BRCA2.	BRCA2 RPA2	4.09e-05	5	71	2	12527904
Pubmed	Murine GBP-5, a new member of the murine guanylate-binding protein family, is coordinately regulated with other GBPs in vivo and in vitro.	GBP5 GBP3	4.09e-05	5	71	2	12396730
Pubmed	Unique features of different members of the human guanylate-binding protein family.	GBP5 GBP3	4.09e-05	5	71	2	17266443
Pubmed	In vivo dissection of a clustered-CTCF domain boundary reveals developmental principles of regulatory insulation.	PARP8 PAX3	4.09e-05	5	71	2	35817979
Pubmed	Intracellular trafficking of guanylate-binding proteins is regulated by heterodimerization in a hierarchical manner.	GBP5 GBP3	4.09e-05	5	71	2	21151871
Pubmed	Identification of potential biomarkers for post-traumatic complications released after trauma-hemorrhage from murine Kupffer cells and its investigation in lung and liver.	GBP5 LCN2	4.09e-05	5	71	2	27120970
Pubmed	Amphiphysin 2 Orchestrates Nucleus Positioning and Shape by Linking the Nuclear Envelope to the Actin and Microtubule Cytoskeleton.	BIN1 SYNE2	4.09e-05	5	71	2	26506308
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	RANBP2 ALMS1 BRCA2 N4BP2 CARMIL1 ARHGAP29 SIK3 RUFY1 DCTN1	5.89e-05	853	71	9	28718761
Pubmed	Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex.	SYNE2 DCLK2 DCTN1	6.03e-05	37	71	3	27565344
Pubmed	A brain-enriched polypyrimidine tract-binding protein antagonizes the ability of Nova to regulate neuron-specific alternative splicing.	PTBP2 HNRNPL	6.13e-05	6	71	2	10829067
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	UBR1 KIF23 ALMS1 SEC23IP PDS5A DCTN1 HNRNPL	6.79e-05	494	71	7	26831064
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	RANBP2 BIN1 ALMS1 SPTB SYNE2 NEB DCTN1	7.05e-05	497	71	7	23414517
Pubmed	Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.	CUL5 PTBP2 ARHGAP26 XRRA1 ERI2 HSF2 FGD6 ALPK2	7.84e-05	686	71	8	29987050
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	BIN1 KIF23 ARHGAP24 RBM33 ARHGAP26 ARHGAP29 PDS5A FGD6 SPATA13	1.01e-04	916	71	9	32203420
Pubmed	BRCA2 controls DNA:RNA hybrid level at DSBs by mediating RNase H2 recruitment.	BRCA2 RPA2	1.14e-04	8	71	2	30560944
Pubmed	In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clusters.	GBP5 GBP3	1.14e-04	8	71	2	16689661
Pubmed	MyoD expression marks the onset of skeletal myogenesis in Myf-5 mutant mice.	PAX3 NEB	1.14e-04	8	71	2	7720554
Pubmed	PPP4C facilitates homologous recombination DNA repair by dephosphorylating PLK1 during early embryo development.	BRCA2 RPA2	1.14e-04	8	71	2	35546066
Pubmed	Human transcription factor protein interaction networks.	KIF23 RESF1 ALMS1 RBM33 SYNE2 GPS2 PDS5A RPA2 SDAD1 HNRNPL FILIP1L	1.44e-04	1429	71	11	35140242
Pubmed	Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases.	GBP5 GBP3	1.47e-04	9	71	2	24739961
Pubmed	Osteoclast fusion and bone loss are restricted by interferon inducible guanylate binding proteins.	GBP5 GBP3	1.47e-04	9	71	2	33479228
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	SCFD2 CUL5 RANBP2 KIF23 SYNE2 PDS5A RARS2 RPA2 NCAPG2 SDAD1 HNRNPL	1.54e-04	1440	71	11	30833792
Pubmed	HIV-1 Vif promotes the G₁- to S-phase cell-cycle transition.	CUL5 HNRNPL	1.83e-04	10	71	2	21149631
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	RESF1 ALMS1 BRCA2 RBM33 N4BP2 HSF2 RUFY1	1.99e-04	588	71	7	38580884
Pubmed	Confirmation of genomewide association signals in Chinese Han population reveals risk loci for ischemic stroke.	SPTB SPATA13	2.23e-04	11	71	2	19910543
Pubmed	Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS.	GBP5 GBP3	2.23e-04	11	71	2	24715728
Pubmed	IRGB10 Liberates Bacterial Ligands for Sensing by the AIM2 and Caspase-11-NLRP3 Inflammasomes.	GBP5 GBP3	2.23e-04	11	71	2	27693356
Pubmed	Homeobox genes and connective tissue patterning.	SPTB PAX3	2.23e-04	11	71	2	7720577
Pubmed	A conserved KASH domain protein associates with telomeres, SUN1, and dynactin during mammalian meiosis.	SYNE2 DCTN1	2.23e-04	11	71	2	22826121
Pubmed	APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer.	BRCA2 PDS5A	2.23e-04	11	71	2	22293751
Pubmed	Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense.	GBP5 GBP3	2.23e-04	11	71	2	18025219
Pubmed	Pathogen-selective killing by guanylate-binding proteins as a molecular mechanism leading to inflammasome signaling.	GBP5 GBP3	2.68e-04	12	71	2	35906252
Pubmed	LPS targets host guanylate-binding proteins to the bacterial outer membrane for non-canonical inflammasome activation.	GBP5 GBP3	2.68e-04	12	71	2	29459437
Pubmed	Junctophilin-2 is necessary for T-tubule maturation during mouse heart development.	CACNA1D BIN1	2.68e-04	12	71	2	23715556
Pubmed	KASH protein Syne-2/Nesprin-2 and SUN proteins SUN1/2 mediate nuclear migration during mammalian retinal development.	SYNE2 DCTN1	3.16e-04	13	71	2	21177258
Pubmed	A meiosis-specific BRCA2 binding protein recruits recombinases to DNA double-strand breaks to ensure homologous recombination.	BRCA2 RPA2	3.16e-04	13	71	2	30760716
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	CUL5 ARHGAP24 SEC23IP ZNF236 NCAPG2 HNRNPL	3.23e-04	451	71	6	36168627
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	RANBP2 RBM33 PTBP2 SEC23IP PDS5A DCTN1 HNRNPL	3.26e-04	638	71	7	33239621
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	SCFD2 GGNBP2 ARHGAP26 SYNE2 SEC23IP SIK3 NEB	3.26e-04	638	71	7	31182584
Pubmed	Impact of lactobacilli on orally acquired listeriosis.	RESF1 GBP5 GBP3 LCN2	3.46e-04	162	71	4	23012479
Pubmed	SUN1/2 and Syne/Nesprin-1/2 complexes connect centrosome to the nucleus during neurogenesis and neuronal migration in mice.	SYNE2 DCTN1	3.68e-04	14	71	2	19874786
Pubmed	Pot1a prevents telomere dysfunction and ATM-dependent neuronal loss.	BRCA2 RPA2	3.68e-04	14	71	2	24899707
Pubmed	Mapping of quantitative trait loci determining NK cell-mediated resistance to MHC class I-deficient bone marrow grafts in perforin-deficient mice.	GBP5 GBP3	4.24e-04	15	71	2	17114464
Pubmed	Guanylate-binding proteins promote activation of the AIM2 inflammasome during infection with Francisella novicida.	GBP5 GBP3	4.24e-04	15	71	2	25774716
Pubmed	A human MAP kinase interactome.	RANBP2 RBM33 N4BP2 SIK3 NEB DCTN1	4.80e-04	486	71	6	20936779
Pubmed	NOVA regulates Dcc alternative splicing during neuronal migration and axon guidance in the spinal cord.	PTBP2 PAX3	4.84e-04	16	71	2	27223328
Pubmed	Rab40-Cullin5 complex regulates EPLIN and actin cytoskeleton dynamics during cell migration.	CUL5 ARHGAP29	4.84e-04	16	71	2	33999101
Pubmed	Elucidation of the Fanconi Anemia Protein Network in Meiosis and Its Function in the Regulation of Histone Modifications.	BRCA2 FANCM	4.84e-04	16	71	2	27760317
Pubmed	A histone-fold complex and FANCM form a conserved DNA-remodeling complex to maintain genome stability.	FANCM RPA2	4.84e-04	16	71	2	20347428
Pubmed	A global genomic transcriptional code associated with CNS-expressed genes.	CARMIL1 CYP7B1 DCLK2 PAX3 GFM1	4.92e-04	318	71	5	16919269
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	TRANK1 RBM33 CARMIL1 NEB RUFY1 SDAD1	5.40e-04	497	71	6	36774506
Pubmed	Genetic analysis of diabetic nephropathy on chromosome 18 in African Americans: linkage analysis and dense SNP mapping.	ZNF236 ALPK2	5.48e-04	17	71	2	19690890
Pubmed	The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection.	GBP5 GBP3	5.48e-04	17	71	2	25774715
Pubmed	Screening E3 substrates using a live phage display library.	RESF1 PDS5A	5.48e-04	17	71	2	24124579
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	ALMS1 CARMIL1 SPTB SYNE2	5.94e-04	187	71	4	26460568
Pubmed	A family of IFN-γ-inducible 65-kD GTPases protects against bacterial infection.	GBP5 GBP3	6.87e-04	19	71	2	21551061
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	RANBP2 KIF23 BRCA2 RBM33 PTBP2 PDS5A FANCM HNRNPL	7.20e-04	954	71	8	36373674
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	BIN1 KIF23 ALMS1 RBM33 N4BP2 SEC23IP GFM1	7.42e-04	733	71	7	34672954
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	LRIG3 TRANK1 USP38 ARHGAP26 SIK3 ERI2	7.47e-04	529	71	6	14621295
Pubmed	Interferon inducible GBPs restrict Burkholderia thailandensis motility induced cell-cell fusion.	GBP5 GBP3	7.62e-04	20	71	2	32150572
Pubmed	A year of COVID-19 GWAS results from the GRASP portal reveals potential genetic risk factors.	CACNA1D RANBP2	7.62e-04	20	71	2	35224516
Pubmed	Cyclical expression of the Notch/Wnt regulator Nrarp requires modulation by Dll3 in somitogenesis.	ARHGAP24 HNRNPL	7.62e-04	20	71	2	19268448
Pubmed	Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.	CUL5 GPS2	8.41e-04	21	71	2	22190037
Pubmed	Scanning the human proteome for calmodulin-binding proteins.	RANBP2 SYNE2 NEB	8.99e-04	92	71	3	15840729
Pubmed	Epistatic interactions between NMD and TRP53 control progenitor cell maintenance and brain size.	PTBP2 HNRNPL	9.24e-04	22	71	2	38697111
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	ADAMTS12 TRANK1 CARMIL1 ARHGAP26 LCN2 HNRNPL	9.31e-04	552	71	6	10737800
Pubmed	Fanconi Anemia	BRCA2 FANCM	1.01e-03	23	71	2	20301575
Pubmed	Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.	ADAMTS12 ADCY5	1.10e-03	24	71	2	32212159
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	CUL5 RANBP2 KIF23 GPS2 PDS5A RARS2 DCTN1 SDAD1 HNRNPL	1.18e-03	1284	71	9	17353931
Pubmed	Interferon-γ primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway.	GBP5 GBP3	1.20e-03	25	71	2	35139355
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	RBM33 PTBP2 GBP3 CYP7B1 LCN2 NEB RUFY1 SPATA13 FILIP1L	1.24e-03	1293	71	9	15342556
Pubmed	ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.	BRCA2 RPA2	1.40e-03	27	71	2	17525332
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	RANBP2 RESF1 RBM33 GPS2 PDS5A RPA2 NCAPG2 HNRNPL	1.81e-03	1103	71	8	34189442
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	RANBP2 GPS2 PDS5A PAX3 RPA2 DCTN1 HNRNPL	1.82e-03	857	71	7	25609649
Pubmed	Polymorphic variants in hereditary pancreatic cancer genes are not associated with pancreatic cancer risk.	BRCA2 FANCM	1.84e-03	31	71	2	19690177
Pubmed	Interaction proteomics identify NEURL4 and the HECT E3 ligase HERC2 as novel modulators of centrosome architecture.	SEC23IP RPA2	1.84e-03	31	71	2	22261722
Pubmed	Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization.	PTBP2 HNRNPL	1.96e-03	32	71	2	36252997
Interaction	H1-2 interactions	CUL5 ARHGAP24 CARMIL1 TRIM31 GBP3 PDS5A XRRA1 NEB RPA2 RUFY1 DCTN1 HNRNPL	2.83e-06	666	70	12	int:H1-2
Interaction	ATAD3B interactions	CUL5 KIF23 ARHGAP24 NEB RPA2 ANKRD55 HNRNPL	9.10e-06	213	70	7	int:ATAD3B
Interaction	ZNF236 interactions	ARHGAP24 ZNF236 HNRNPL	1.42e-05	14	70	3	int:ZNF236
Interaction	EYA4 interactions	RESF1 ALMS1 BRCA2 RBM33 GPS2 TRIM31 RPA2	2.14e-05	243	70	7	int:EYA4
Interaction	TMPRSS2 interactions	KIF23 RBM33 CGRRF1 SPTB SYNE2 SEC23IP RPA2 HNRNPL	2.16e-05	337	70	8	int:TMPRSS2
Interaction	BICD1 interactions	RANBP2 N4BP2 CARMIL1 ARHGAP29 SIK3 DCTN1 HNRNPL	2.56e-05	250	70	7	int:BICD1
Interaction	SNRNP200 interactions	CUL5 RANBP2 KIF23 RBM33 TRIM31 PDS5A RPA2 RUFY1 ANKRD55	2.95e-05	460	70	9	int:SNRNP200
Interaction	HNRNPAB interactions	CUL5 KIF23 PTBP2 N4BP2 TRIM31 GFM1 RPA2 HNRNPL	4.27e-05	371	70	8	int:HNRNPAB
Interaction	ADAR interactions	RANBP2 KIF23 ARHGAP24 USP38 PDS5A RPA2 HNRNPL	6.02e-05	286	70	7	int:ADAR
Interaction	IGF2BP1 interactions	CUL5 BIN1 KIF23 ARHGAP24 SEC23IP TRIM31 RPA2 RUFY1 HNRNPL	6.35e-05	508	70	9	int:IGF2BP1
Interaction	PFN1 interactions	RANBP2 ARHGAP24 ALMS1 N4BP2 CARMIL1 SYNE2 ARHGAP29 RPA2 RUFY1	6.45e-05	509	70	9	int:PFN1
Interaction	CCT4 interactions	CUL5 KIF23 ARHGAP24 SEC23IP TRIM31 SIK3 RPA2 RUFY1 ANKRD55	7.06e-05	515	70	9	int:CCT4
Interaction	MATR3 interactions	RANBP2 KIF23 ARHGAP24 PTBP2 TRIM31 PDS5A RPA2 RUFY1 DCTN1 HNRNPL	8.39e-05	655	70	10	int:MATR3
Interaction	DPPA3 interactions	RANBP2 ALMS1 BRCA2 LCN2	8.67e-05	67	70	4	int:DPPA3
Interaction	KDM1A interactions	RANBP2 RESF1 ALMS1 USP38 BRCA2 N4BP2 SEC23IP ARHGAP29 PDS5A RPA2 RUFY1 DCTN1	8.72e-05	941	70	12	int:KDM1A
Interaction	YWHAH interactions	KIF23 RESF1 ALMS1 CARMIL1 PARP8 SYNE2 DCLK2 SIK3 RPA2 DCTN1 FGD6 ANKRD55 SPATA13	9.41e-05	1102	70	13	int:YWHAH
Interaction	KHSRP interactions	CUL5 KIF23 ARHGAP24 PTBP2 SEC23IP TRIM31 RPA2	9.57e-05	308	70	7	int:KHSRP
Interaction	YWHAQ interactions	KIF23 PARP8 SPTB TRIM31 DCLK2 SIK3 NEB RPA2 RUFY1 FGD6 ANKRD55 HNRNPL SPATA13	1.09e-04	1118	70	13	int:YWHAQ
Interaction	DDX17 interactions	RANBP2 KIF23 ARHGAP24 TRIM31 RPA2 RUFY1 SDAD1 HNRNPL	1.12e-04	426	70	8	int:DDX17
Interaction	CBS interactions	KIF23 ARHGAP24 ARHGAP26 ARHGAP29 RPA2	1.15e-04	137	70	5	int:CBS
Interaction	RUFY3 interactions	ADAMTS12 BRCA2 RPA2 RUFY1	1.15e-04	72	70	4	int:RUFY3
Interaction	XPOT interactions	CUL5 RANBP2 ARHGAP24 RPA2 RUFY1 ANKRD55	1.16e-04	220	70	6	int:XPOT
Interaction	PLEC interactions	KIF23 BRCA2 N4BP2 SYNE2 FANCM RPA2 HNRNPL FILIP1L	1.19e-04	430	70	8	int:PLEC
Interaction	TUFM interactions	CUL5 KIF23 ARHGAP24 TRIM31 RARS2 GFM1 RPA2 RUFY1 ANKRD55 HNRNPL	1.23e-04	686	70	10	int:TUFM
Interaction	RABL2A interactions	ALMS1 BRCA2 SEC23IP	1.24e-04	28	70	3	int:RABL2A
Interaction	TUBB4B interactions	CUL5 RANBP2 ALMS1 TRIM31 ARHGAP29 RPA2 RUFY1 DCTN1 ANKRD55	1.33e-04	560	70	9	int:TUBB4B
Interaction	GUSBP5 interactions	KIF23 ALMS1 BRCA2 GPS2	1.35e-04	75	70	4	int:GUSBP5
Interaction	DPYSL2 interactions	CUL5 CGRRF1 DCLK2 GFM1 RPA2 FGD6 HNRNPL	1.39e-04	327	70	7	int:DPYSL2
Interaction	ATAD3A interactions	KIF23 ARHGAP24 NEB RPA2 RUFY1 ANKRD55 HNRNPL	1.47e-04	330	70	7	int:ATAD3A
Interaction	YWHAZ interactions	BIN1 KIF23 PARP8 SYNE2 ARHGAP29 SIK3 NEB RPA2 RUFY1 DCTN1 FGD6 ANKRD55 HNRNPL SPATA13	1.50e-04	1319	70	14	int:YWHAZ
Interaction	ESCO1 interactions	BRCA2 PDS5A HNRNPL	1.52e-04	30	70	3	int:ESCO1
Interaction	ACLY interactions	CUL5 KIF23 ARHGAP24 CARMIL1 RPA2 RUFY1 ANKRD55	1.61e-04	335	70	7	int:ACLY
Interaction	YARS2 interactions	KIF23 RBMS3 SPTB RARS2 GFM1 RPA2	1.66e-04	235	70	6	int:YARS2
Interaction	DFFB interactions	CUL5 RPA2 HNRNPL	1.68e-04	31	70	3	int:DFFB
Interaction	UPF1 interactions	CUL5 KIF23 BRCA2 TRIM31 LCN2 RPA2 DCTN1 ANKRD55 HNRNPL	1.76e-04	581	70	9	int:UPF1
Interaction	SLC16A14 interactions	BRCA2 HNRNPL	1.77e-04	6	70	2	int:SLC16A14
Interaction	CLBA1 interactions	KIF23 HNRNPL	1.77e-04	6	70	2	int:CLBA1
Interaction	MARS1 interactions	KIF23 ARHGAP24 PDS5A RPA2 RUFY1 ANKRD55 HNRNPL	1.86e-04	343	70	7	int:MARS1
Interaction	PHF21A interactions	RANBP2 RESF1 ALMS1 BRCA2 SEC23IP RPA2 RUFY1	1.86e-04	343	70	7	int:PHF21A
Interaction	EEF2 interactions	CUL5 BIN1 KIF23 ARHGAP24 TRIM31 RPA2 RUFY1 ANKRD55 HNRNPL	1.92e-04	588	70	9	int:EEF2
Interaction	NAP1L1 interactions	CUL5 KIF23 TRIM31 RPA2 RUFY1 DCTN1 SDAD1	1.93e-04	345	70	7	int:NAP1L1
Interaction	LRRC41 interactions	CUL5 ARHGAP24 RPA2 HNRNPL	1.99e-04	83	70	4	int:LRRC41
Interaction	RAB40B interactions	CUL5 ARHGAP29 HNRNPL	2.03e-04	33	70	3	int:RAB40B
Interaction	AGAP3 interactions	ARHGAP24 RPA2 DCTN1 HNRNPL	2.09e-04	84	70	4	int:AGAP3
Interaction	NCBP1 interactions	CUL5 KIF23 ARHGAP24 SEC23IP HSF2 RPA2 HNRNPL	2.22e-04	353	70	7	int:NCBP1
Interaction	DCLK2 interactions	DCLK2 DCTN1 HNRNPL	2.22e-04	34	70	3	int:DCLK2
Interaction	MCM3 interactions	KIF23 ARHGAP24 TRIM31 RPA2 RUFY1 DCTN1 ANKRD55	2.29e-04	355	70	7	int:MCM3
Interaction	HNRNPF interactions	CUL5 RANBP2 KIF23 PTBP2 SEC23IP TRIM31 RPA2 RUFY1 HNRNPL	2.43e-04	607	70	9	int:HNRNPF
Interaction	EME2 interactions	BRCA2 FANCM	2.47e-04	7	70	2	int:EME2
Interaction	PCMT1 interactions	KIF23 ARHGAP24 TRIM31 ARHGAP29 RPA2 RUFY1	2.63e-04	256	70	6	int:PCMT1
Interaction	DYNC1H1 interactions	KIF23 BRCA2 SEC23IP RPA2 RUFY1 DCTN1 ANKRD55 HNRNPL	2.94e-04	491	70	8	int:DYNC1H1
Interaction	KHDRBS1 interactions	KIF23 ARHGAP24 PTBP2 TRIM31 RPA2 HNRNPL SPATA13	3.10e-04	373	70	7	int:KHDRBS1
Interaction	NXN interactions	RPA2 RUFY1 HNRNPL	3.10e-04	38	70	3	int:NXN
Interaction	GNAS interactions	KIF23 ARHGAP26 SYNE2 RPA2 ADCY5 HNRNPL	3.10e-04	264	70	6	int:GNAS
Interaction	PCNA interactions	CUL5 RANBP2 BRCA2 SEC23IP TRIM31 FANCM RPA2 ANKRD55	3.19e-04	497	70	8	int:PCNA
Interaction	PKM interactions	CUL5 ARHGAP24 SYNE2 TRIM31 RPA2 RUFY1 ANKRD55 HNRNPL	3.19e-04	497	70	8	int:PKM
Interaction	RTCB interactions	CUL5 KIF23 N4BP2 TRIM31 RARS2 RPA2 ANKRD55	3.20e-04	375	70	7	int:RTCB
Interaction	ACTB interactions	CUL5 ARHGAP24 ALMS1 SPTB SEC23IP TRIM31 PDS5A NEB RPA2 DCTN1 ANKRD55 HNRNPL	3.23e-04	1083	70	12	int:ACTB
Interaction	THAP5 interactions	THAP5 KIF23	3.29e-04	8	70	2	int:THAP5
Interaction	DHX15 interactions	CUL5 RANBP2 KIF23 ARHGAP24 TRIM31 RPA2 RUFY1 HNRNPL	3.42e-04	502	70	8	int:DHX15
Interaction	YWHAE interactions	KIF23 PARP8 SEC23IP COL6A5 DCLK2 SIK3 RPA2 RUFY1 DCTN1 FGD6 ANKRD55 HNRNPL SPATA13	3.42e-04	1256	70	13	int:YWHAE
Interaction	CKB interactions	CUL5 ARHGAP24 USP38 RPA2 ANKRD55 HNRNPL	3.50e-04	270	70	6	int:CKB
Interaction	FARSA interactions	KIF23 ARHGAP29 RPA2 RUFY1 ANKRD55	3.87e-04	178	70	5	int:FARSA
Interaction	IGF2 interactions	UBR1 TRIM31 HNRNPL	4.18e-04	42	70	3	int:IGF2
Interaction	TIMM44 interactions	KIF23 ARHGAP26 SYNE2 GFM1 RPA2 ANKRD55	4.24e-04	280	70	6	int:TIMM44
Interaction	CLTC interactions	CUL5 RANBP2 BIN1 KIF23 RPA2 RUFY1 DCTN1 ANKRD55 HNRNPL	4.25e-04	655	70	9	int:CLTC
Interaction	KPNA2 interactions	RANBP2 KIF23 TRIM31 RPA2 RUFY1 DCTN1 ANKRD55 SDAD1	4.26e-04	519	70	8	int:KPNA2
Interaction	HSP90AB1 interactions	CUL5 KIF23 ARHGAP24 BRCA2 TRIM31 DCLK2 SIK3 NEB RPA2 RUFY1 ANKRD55	4.44e-04	960	70	11	int:HSP90AB1
Interaction	KYAT3 interactions	CUL5 RPA2 HNRNPL	4.48e-04	43	70	3	int:KYAT3
Interaction	SYNJ2 interactions	RPA2 DCTN1 HNRNPL	4.48e-04	43	70	3	int:SYNJ2
Interaction	RPLP0 interactions	CUL5 RANBP2 KIF23 TRIM31 RPA2 RUFY1 ANKRD55 SDAD1 HNRNPL	4.49e-04	660	70	9	int:RPLP0
Interaction	DHX9 interactions	CUL5 RANBP2 BIN1 KIF23 TRIM31 RPA2 RUFY1 ANKRD55 HNRNPL	4.59e-04	662	70	9	int:DHX9
Interaction	AKTIP interactions	PDS5A NEB DCTN1 HNRNPL	4.72e-04	104	70	4	int:AKTIP
Interaction	MYH14 interactions	KIF23 BRCA2 TRIM31 RPA2 HNRNPL	5.08e-04	189	70	5	int:MYH14
Interaction	ALDH18A1 interactions	KIF23 ARHGAP24 RPA2 RUFY1 ANKRD55	5.08e-04	189	70	5	int:ALDH18A1
Interaction	H2BC3 interactions	RANBP2 ARHGAP24 USP38 PDS5A RPA2 RUFY1 DCTN1	5.15e-04	406	70	7	int:H2BC3
Interaction	ENO3 interactions	ARHGAP24 SPTB NEB DCTN1	5.26e-04	107	70	4	int:ENO3
Interaction	FMR1 interactions	RANBP2 BIN1 KIF23 ARHGAP24 N4BP2 TRIM31 SIK3 HNRNPL	5.27e-04	536	70	8	int:FMR1
Interaction	PLBD2 interactions	CARMIL1 RPA2 HNRNPL	5.47e-04	46	70	3	int:PLBD2
Interaction	MCM7 interactions	CUL5 ARHGAP24 SIK3 RPA2 DCTN1 C8orf34 ANKRD55	5.78e-04	414	70	7	int:MCM7
Cytoband	2p13	ALMS1 DCTN1	5.84e-04	23	71	2	2p13
Cytoband	7q36.3	RBM33 NCAPG2	6.37e-04	24	71	2	7q36.3
Cytoband	1p22.2	GBP5 GBP3	8.68e-04	28	71	2	1p22.2
Cytoband	Ensembl 112 genes in cytogenetic band chr1p22	GBP5 ARHGAP29 GBP3	1.28e-03	137	71	3	chr1p22
Cytoband	4p14	N4BP2 PDS5A	1.95e-03	42	71	2	4p14
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP24 ARHGAP26 ARHGAP29	3.15e-04	50	48	3	721
GeneFamily	Ring finger proteins\|Fanconi anemia complementation groups\|Protein phosphatase 1 regulatory subunits\|BRCA1 A complex\|BRCA1 B complex\|BRCA1 C complex	BRCA2 FANCM	1.27e-03	20	48	2	548
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGAP24 SPTB FGD6 SPATA13	2.15e-03	206	48	4	682
GeneFamily	RNA binding motif containing	RBMS3 RBM33 PTBP2 HNRNPL	2.43e-03	213	48	4	725
GeneFamily	Zinc fingers FYVE-type\|Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors	RUFY1 FGD6	3.06e-03	31	48	2	81
Coexpression	GSE24210_RESTING_TREG_VS_TCONV_UP	BIN1 N4BP2 CARMIL1 ARHGAP26 SYNE2 DCLK2 RUFY1	1.19e-06	200	71	7	M7839
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN	RANBP2 GGNBP2 USP38 RBM33 PTBP2 CGRRF1 PDS5A SIK3 HNRNPL SPATA13	1.43e-05	680	71	10	M41089
Coexpression	HALLMARK_MITOTIC_SPINDLE	BIN1 KIF23 ALMS1 BRCA2 ARHGAP29 FGD6	1.69e-05	199	71	6	M5893
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	UBR1 RANBP2 BIN1 GGNBP2 TRANK1 RESF1 GBP5 RBM33 PARP8 GBP3 PDS5A SIK3 RPA2 SPATA13	3.99e-05	1492	71	14	M40023
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	ALMS1 BRCA2 PTBP2 SYNE2 PDS5A CFAP210 FGD6	2.98e-06	192	69	7	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RANBP2 GBP5 SYNE2 ARHGAP29 GBP3 FILIP1L	4.08e-07	178	71	6	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	normal_Lung-Myeloid_cells-CD207+CD1a+_LCs\|Myeloid_cells / Location, Cell class and cell subclass	CACNA1D CD1A KIF23 DCLK2 ALPK2 FILIP1L	4.65e-07	182	71	6	8dd79fef8f8463ad3194f9cc07c6cacf2c886304
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RESF1 GBP5 ARHGAP26 PARP8 SYNE2 SPATA13	6.55e-07	193	71	6	a594f89a18273797506287d9e22f72abe53e4920
ToppCell	Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC\|Transverse / shred on region, Cell_type, and subtype	SPTB DCLK2 NEB FGD6 ALPK2 FILIP1L	7.38e-07	197	71	6	15b87fd3906d7388c271d30d0c64b1bcc490801c
ToppCell	Transverse-Dendritic_cell-Lymphoid_DC\|Transverse / Region, Cell class and subclass	SPTB DCLK2 NEB FGD6 ALPK2 FILIP1L	7.38e-07	197	71	6	a58af0ea82f76f2a7abac1f62629ff20d552fc63
ToppCell	Macroglial-Astrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ARHGAP24 RBMS3 CARMIL1 ARHGAP26 DCLK2 FGD6	8.06e-07	200	71	6	941536b7c32f1e63c70535233b2ccce0cd7bf96e
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|356C / Donor, Lineage, Cell class and subclass (all cells)	RESF1 ARHGAP26 PARP8 SYNE2 CFAP210	6.88e-06	166	71	5	c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TRANK1 RESF1 GBP5 PARP8 SYNE2	7.95e-06	171	71	5	e6dfbd2652b67577c8834c05348f62150637f348
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TRANK1 RESF1 GBP5 PARP8 SYNE2	7.95e-06	171	71	5	ddaeb96ce9c9c3bf232b4a42266fa2ee7e8f3f41
ToppCell	normal_Lung-Myeloid_cells-CD207+CD1a+_LCs\|normal_Lung / Location, Cell class and cell subclass	CD1A KIF23 DCLK2 ALPK2 FILIP1L	1.05e-05	181	71	5	b55dbcfae8c92d322071906831489830a22239b9
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KIF23 ARHGAP24 SYNE2 ARHGAP29 ADCY5	1.26e-05	188	71	5	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	3'_v3-Lung-Myeloid_Dendritic-Cycling_Dendritic\|Lung / Manually curated celltypes from each tissue	CD1A KIF23 DCLK2 NCAPG2 CCDC26	1.26e-05	188	71	5	0e8ac42c439f30a05e015210e1d5c2dcb9d9d471
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-Trm_Th1/Th17\|Lung / Manually curated celltypes from each tissue	RESF1 GBP5 PARP8 SYNE2 SIK3	1.29e-05	189	71	5	f43960506ed3e699e910ec7711c1113e2e9b80d1
ToppCell	T_cells-GZMK+_CD8+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	RESF1 GBP5 PARP8 SYNE2 SPATA13	1.29e-05	189	71	5	e2ca075aedf7c370ab4ede6272254ffd06cbcdec
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	GBP5 PARP8 SYNE2 GBP3 SPATA13	1.46e-05	194	71	5	866a9ca4c93c3c79c709a9d00def5392197f7e18
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TRANK1 RESF1 GBP5 PARP8 SYNE2	1.50e-05	195	71	5	662b50a2aa97373bf343b88caace9717049c722a
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TRANK1 RESF1 GBP5 PARP8 SYNE2	1.50e-05	195	71	5	9b7157b5e4b81bc35b0e6d9b954279160ea57324
ToppCell	healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	RESF1 GBP5 PARP8 SYNE2 SPATA13	1.54e-05	196	71	5	af00c31612e4fe068e5fccae05368edba46bbd20
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RESF1 GBP5 N4BP2 PARP8 SYNE2	1.54e-05	196	71	5	4a880a5d2c7047c050c7d6dd62186f35dc5c01f7
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	TRANK1 RESF1 GBP5 PARP8 SYNE2	1.58e-05	197	71	5	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADAMTS12 CACNA1D RBMS3 CYP7B1 FILIP1L	1.58e-05	197	71	5	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRANK1 RESF1 GBP5 PARP8 SYNE2	1.58e-05	197	71	5	927bf36bad3bcb7346c13b660777c1c0de7dc322
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRANK1 RESF1 GBP5 PARP8 SYNE2	1.58e-05	197	71	5	3e09158507df08c08e08613ce23617206280c911
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	ADAMTS12 CACNA1D ARHGAP24 CYP7B1 SPATA13	1.58e-05	197	71	5	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	RESF1 GBP5 PARP8 SYNE2 SPATA13	1.61e-05	198	71	5	1ca6cd8e75891fdfaddbb4a7342eec9ca4d11e5d
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-effector_CD8-positive,_alpha-beta_T_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RESF1 GBP5 ARHGAP26 PARP8 SYNE2	1.61e-05	198	71	5	41ead3d3733b79e3e45648d5ce1909e617c35ed7
ToppCell	VE-CD8\|VE / Condition, Cell_class and T cell subcluster	RESF1 GBP5 ARHGAP26 PARP8 SYNE2	1.65e-05	199	71	5	9ae4d3e93b6e0861258e567c901ec34f04ded547
ToppCell	Hematolymphoid-Endothelial-NOSTRIN\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	RBMS3 SYNE2 ARHGAP29 CYP7B1 FGD6	1.69e-05	200	71	5	032df80aa5c40991e1c1e80f9d8da106e6aeaee2
ToppCell	mild-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TRANK1 RESF1 GBP5 PARP8 SYNE2	1.69e-05	200	71	5	d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCell	Macroglial-Astrocytes-SLC14A1---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ARHGAP24 RBMS3 CARMIL1 ARHGAP26 FGD6	1.69e-05	200	71	5	d6fcbf4f4bc1b89a9929d7b114c6b907b6979900
ToppCell	Macroglial-Astrocytes-SLC14A1----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ARHGAP24 RBMS3 CARMIL1 ARHGAP26 FGD6	1.69e-05	200	71	5	f861509b54185d89931db64da1b9d81986cc7938
ToppCell	LPS_IL1RA\|World / Treatment groups by lineage, cell group, cell type	RESF1 ARHGAP26 SYNE2 GBP3 FILIP1L	1.69e-05	200	71	5	a02fa5b3c4723a6eaa3c685588666c710478dd25
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	ADAMTS12 CACNA1D RBMS3 CYP7B1 COL6A5	1.69e-05	200	71	5	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Hematolymphoid-Endothelial-NOSTRIN---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	RBMS3 SYNE2 ARHGAP29 CYP7B1 FGD6	1.69e-05	200	71	5	68fce28690246895fd33354b30960ebcc31aa4cc
ToppCell	Sepsis-URO-Lymphocyte-T/NK-CD8+_Tem\|URO / Disease, condition lineage and cell class	BIN1 RESF1 GBP5 PARP8 SYNE2	1.69e-05	200	71	5	e621b46084839700e6dd338fdafc682a07cd698d
ToppCell	Hematolymphoid-Endothelial-NOSTRIN-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	RBMS3 SYNE2 ARHGAP29 CYP7B1 FGD6	1.69e-05	200	71	5	376b19ab5a7cd2c85f726d8ba41337d4525863e5
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ADAMTS12 CACNA1D RBMS3 CYP7B1 COL6A5	1.69e-05	200	71	5	a510deaada669e690329183e18df02870bd204b3
ToppCell	VE\|World / Condition, Cell_class and T cell subcluster	TRANK1 RESF1 GBP5 PARP8 SYNE2	1.69e-05	200	71	5	8ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCell	Macroglial-Astrocytes-SLC14A1\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ARHGAP24 RBMS3 CARMIL1 ARHGAP26 FGD6	1.69e-05	200	71	5	16f468217427921fa18c6d078ffa990eb019b257
ToppCell	Hematolymphoid-Endothelial-NOSTRIN--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	RBMS3 SYNE2 ARHGAP29 CYP7B1 FGD6	1.69e-05	200	71	5	7fa54370221ed61bac0e09e6bcf1f3dff202a846
ToppCell	Macroglial-Astrocytes-SLC14A1--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ARHGAP24 RBMS3 CARMIL1 ARHGAP26 FGD6	1.69e-05	200	71	5	0442894c39eec69850c090957a5dc7bcecd21e04
ToppCell	mild-CD8+_Tem\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BIN1 RESF1 GBP5 PARP8 SYNE2	1.69e-05	200	71	5	a7870c5728b2c17d1d0e4fe728599f186966861b
ToppCell	Macroglial-Astrocytes-SLC14A1-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ARHGAP24 RBMS3 CARMIL1 ARHGAP26 FGD6	1.69e-05	200	71	5	01819446deeab9054f5cfe889d53bb49d137dbc0
ToppCell	Hematolymphoid-Endothelial-NOSTRIN----L2-6\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	RBMS3 SYNE2 ARHGAP29 CYP7B1 FGD6	1.69e-05	200	71	5	878bbbe32e3602723aa14ef32877ab2453b8c6e5
ToppCell	Hematolymphoid-Endothelial\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	RBMS3 SYNE2 ARHGAP29 CYP7B1 FGD6	1.69e-05	200	71	5	7136936d05ab344a560cf159684c881063b5430d
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADAMTS12 CACNA1D RBMS3 CYP7B1 COL6A5	1.69e-05	200	71	5	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	Control-Fibroblasts-Mesothelial_FB\|Control / group, cell type (main and fine annotations)	CYP7B1 ANKRD55 ADCY5 ALPK2	7.22e-05	139	71	4	e769beb031b262dd92c9605b07dbf3c29fb82520
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-Tfh\|Lung / Manually curated celltypes from each tissue	RESF1 SYNE2 TRIM31 ANKRD55	7.84e-05	142	71	4	319812c84fad93276bf093f2ad78db02ae745bf4
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BIN1 SPTB PAX3 NEB	8.28e-05	144	71	4	f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	RESF1 DNAJC9-AS1 RBMS3 SYNE2	1.05e-04	153	71	4	7518187a5fbf6c0881182dc79bd37c2d49f92b2e
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RESF1 DNAJC9-AS1 RBMS3 SYNE2	1.05e-04	153	71	4	93d36723f01c2df39feebf20f3eba5b4fb4cdf59
ToppCell	IIH-Treg\|IIH / Condition, Cell_class and T cell subcluster	RESF1 GBP5 BRCA2 CYP7B1	1.05e-04	153	71	4	17704e18833812fcf2a2727b1e3f8a9984ba5b59
ToppCell	IIH-Treg-CD4_Treg\|IIH / Condition, Cell_class and T cell subcluster	RESF1 GBP5 BRCA2 CYP7B1	1.07e-04	154	71	4	d2211a892654b92decb208969040920f7ae8ba1e
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|Heart / Disease (COVID-19 only), tissue and cell type	BIN1 SPTB PAX3 NEB	1.10e-04	155	71	4	d7e26696fd9c0a759524f331243db43059b33ed9
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF23 BRCA2 DCLK2 RPA2	1.21e-04	159	71	4	e9c51e611ebd427bbe51e3e036c14122c36ea372
ToppCell	TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-7\|TCGA-Cervix / Sample_Type by Project: Shred V9	CACNA1D MYO7B ARHGAP26 TRIM31	1.21e-04	159	71	4	75a82bbabd97b168dbf1c3f43a9bdad48ce18c78
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	ADAMTS12 SPTB DCLK2 ADCY5	1.24e-04	160	71	4	fd14dfeb7021a4b7299371854dc8fc1fd66c8dae
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GBP5 SYNE2 TMC3 ALPK2	1.24e-04	160	71	4	79e833c904c762434993b5ec9d5e3540e695fad3
ToppCell	cellseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-ILC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RESF1 GBP5 DNAJC9-AS1 PARP8	1.30e-04	162	71	4	553f91eaba72bcffb733ede45418bbee39c653ab
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	UBR1 TRANK1 GBP5 GBP3	1.34e-04	163	71	4	d005115aa1e1458b51de7eb719794617a4168608
ToppCell	PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte2_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SPTB KBTBD12 LCN2 ANKRD55	1.40e-04	165	71	4	d2ab667ff53f538b12ee4e07ea4b4d118600a228
ToppCell	Dividing_Macrophages-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	KIF23 BRCA2 MYO7B NCAPG2	1.43e-04	166	71	4	c503036f3c19ef186e1e62c9643c49dea3827f51
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	TRANK1 NEB ANKRD55 NCAPG2	1.47e-04	167	71	4	c0c944eae0514dc8e00d0c2892a0792e157695ec
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Trm_gut_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	RESF1 GBP5 PARP8 SYNE2	1.47e-04	167	71	4	69de7d7fc69d699eab03dfea84fdb54263aa5a47
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RESF1 PARP8 SPTB SYNE2	1.50e-04	168	71	4	07be11b6f0f37106e219692db5795c6dd32807c9
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIF23 BRCA2 ERI2 NCAPG2	1.53e-04	169	71	4	e0607af8ae8609d43e26ff2a2cab92650bfcd5b7
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231\|Adult / Lineage, Cell type, age group and donor	LRIG3 SYNE2 C8orf34 FGD6	1.57e-04	170	71	4	269dee5abca9f6aa079f116f0d8f1d198604d9d4
ToppCell	PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte2_(17)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SPTB KBTBD12 LCN2 ANKRD55	1.57e-04	170	71	4	3886a77bc3ddbeb42a8149b759fe578871676d6e
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRANK1 GBP5 CARMIL1 GBP3	1.57e-04	170	71	4	07b561cd9c528bc8444c9385e1de621eee7b697e
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	RESF1 ARHGAP26 PARP8 CFAP210	1.64e-04	172	71	4	a9e13aa36087170dadca421ba9de588e5a1cf715
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	RBMS3 ARHGAP29 ADCY5 ALPK2	1.64e-04	172	71	4	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP26 ARHGAP29 C8orf34 ALPK2	1.75e-04	175	71	4	284fdc7a9d303636a637041846850d19d114861a
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-plasma_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KBTBD12 TMC3 ANKRD55 ALPK2	1.79e-04	176	71	4	35610e7ac9902687e222641202409bab279c3998
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GBP5 SYNE2 ARHGAP29 GBP3	1.83e-04	177	71	4	ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GBP5 SYNE2 ARHGAP29 GBP3	1.83e-04	177	71	4	f471f7747d6e8db7546899019af9508f48a14f89
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GBP5 SYNE2 ARHGAP29 GBP3	1.83e-04	177	71	4	cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_1\|367C / Donor, Lineage, Cell class and subclass (all cells)	CD1A KIF23 BRCA2 NCAPG2	1.83e-04	177	71	4	ba701d3c90722d8bff70d0fa651899305cdad257
ToppCell	BAL-Mild-cDC_4\|Mild / Compartment, Disease Groups and Clusters	SYNE2 FANCM DCTN1 ANKRD55	1.91e-04	179	71	4	68511e87b12b8253de7771e5ccfc5869248b8450
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega\|lymph-node_spleen / Manually curated celltypes from each tissue	KBTBD12 COL6A5 LCN2 CCDC26	1.91e-04	179	71	4	4e0cf069bc47328eda753a4edc7e89b8915d52bb
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BIN1 MYO7B ARHGAP26 ALPK2	1.91e-04	179	71	4	58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428
ToppCell	LPS-IL1RA-Endothelial-Endothelial-FOXM1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIF23 BRCA2 ERI2 NCAPG2	1.95e-04	180	71	4	334e2b1f6eb7d4ece20b1c7b02107863f913237f
ToppCell	COVID-19-Heart-Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADAMTS12 RBMS3 ARHGAP26 ADCY5	1.99e-04	181	71	4	33cac65ed1ea5e7bd72250495df4f850b143d5aa
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF23 SYNE2 LCN2 NCAPG2	1.99e-04	181	71	4	566249e04dd491e6287ad2101b7b1ab11031ed8b
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADAMTS12 CACNA1D CYP7B1 COL6A5	1.99e-04	181	71	4	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF23 SYNE2 LCN2 NCAPG2	1.99e-04	181	71	4	db9528dc7cb0230e4c36cb27da69102c588c7ee9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KIF23 BRCA2 ERI2 NCAPG2	2.04e-04	182	71	4	336cd05e46a741185ce3c59ee67a4b07fa6a5101
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	RESF1 GBP5 ARHGAP26 PARP8	2.04e-04	182	71	4	f857b32de19240a8aca1685f7a78b4e53b04875c
ToppCell	normal-na-Lymphocytic_T-CytoT_GZMK+-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	RESF1 GBP5 PARP8 SYNE2	2.08e-04	183	71	4	79defd22b3194dad16db55b9bdd220c09c1e6b90
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	TRANK1 SYNE2 GBP3 FGD6	2.08e-04	183	71	4	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega-Erythrocytic_early\|lymph-node_spleen / Manually curated celltypes from each tissue	CYP7B1 COL6A5 LCN2 CCDC26	2.08e-04	183	71	4	0d56e16d4868c752c7557acec212029eb469ed05
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	BIN1 MYO7B SYNE2 ALPK2	2.12e-04	184	71	4	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTB KBTBD12 ADCY5 ALPK2	2.12e-04	184	71	4	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTB KBTBD12 ADCY5 ALPK2	2.17e-04	185	71	4	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD1A TRANK1 GBP5 GBP3	2.17e-04	185	71	4	f30fb9d75cdb757b206312992aaf7485bc900f96
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CGRRF1 KBTBD12 CFAP210 LCN2	2.17e-04	185	71	4	709236097cbfc254796fcc69b5f5178b73dad9bd
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CGRRF1 KBTBD12 CFAP210 LCN2	2.17e-04	185	71	4	af078a6c4a3e0b54b7d8ab7b30dcd06053ebfd28
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ADAMTS12 ARHGAP24 RBMS3 DCLK2	2.21e-04	186	71	4	cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAMTS12 RBMS3 PTBP2 FILIP1L	2.21e-04	186	71	4	f07e0c0d9c80ac9d8d679950e7d0c812becb85a3
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	UBR1 TRANK1 RESF1 ALMS1	2.21e-04	186	71	4	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAMTS12 SPTB CYP7B1 FILIP1L	2.21e-04	186	71	4	0c477016c1b539b3086a8066c3c6443f08c222a3
Computational	Neighborhood of DDX11	RANBP2 SPTB SIK3 RPA2 HNRNPL	2.06e-04	156	38	5	MORF_DDX11
Disease	platelet crit	SCFD2 GMCL2 USP38 CARMIL1 ARHGAP29 RPA2 NCAPG2 CCDC26 ADCY5 SPATA13	7.07e-05	952	69	10	EFO_0007985
Disease	total hip arthroplasty, osteoarthritis	LRIG3 C8orf34 CCDC26	1.32e-04	42	69	3	EFO_0009806, MONDO_0005178
Disease	lung carcinoma	GPLD1 BRCA2 RBMS3 CARMIL1 COL6A5 RUFY1 SDAD1	1.34e-04	482	69	7	EFO_0001071
Disease	level of Ceramide (d40:1) in blood serum	SYNE2 SIK3	2.92e-04	11	69	2	OBA_2045185
Disease	MYELODYSPLASTIC SYNDROME	BRCA2 ARHGAP26 FANCM	5.27e-04	67	69	3	C3463824
Disease	retinopathy	CYP7B1 CCDC26	7.16e-04	17	69	2	EFO_0003839
Disease	Bone marrow hypocellularity	BRCA2 FANCM	8.05e-04	18	69	2	C1855710
Disease	diastolic blood pressure, systolic blood pressure	SCFD2 CACNA1D LRIG3 ALMS1 RBM33 N4BP2 CARMIL1	9.62e-04	670	69	7	EFO_0006335, EFO_0006336
Disease	Deaf Mutism	CACNA1D PAX3	9.96e-04	20	69	2	C4082305
Disease	Deafness, Acquired	CACNA1D PAX3	9.96e-04	20	69	2	C0751068
Disease	Hearing Loss, Extreme	CACNA1D PAX3	9.96e-04	20	69	2	C0086395
Disease	Complete Hearing Loss	CACNA1D PAX3	9.96e-04	20	69	2	C0581883
Disease	Prelingual Deafness	CACNA1D PAX3	9.96e-04	20	69	2	C0011052
Disease	Bilateral Deafness	CACNA1D PAX3	9.96e-04	20	69	2	C3665473
Disease	nose morphology measurement	ARHGAP24 RESF1 PAX3 CCDC26 FILIP1L	1.05e-03	329	69	5	EFO_0007843
Disease	eye color	TRANK1 CARMIL1 CCDC26	1.24e-03	90	69	3	EFO_0003949
Disease	pulse pressure measurement	CACNA1D LRIG3 ARHGAP24 TRANK1 RBM33 CARMIL1 ARHGAP26 FGD6 ADCY5 FILIP1L	1.42e-03	1392	69	10	EFO_0005763
Disease	HDL cholesterol change measurement	SYNE2 DCLK2	1.44e-03	24	69	2	EFO_0007805
Disease	myeloid white cell count	SCFD2 BIN1 ARHGAP26 SIK3 HSF2 RPA2 CCDC26 ADCY5	1.51e-03	937	69	8	EFO_0007988
Disease	Fanconi Anemia	BRCA2 FANCM	1.56e-03	25	69	2	C0015625
Disease	Deafness	CACNA1D PAX3	1.56e-03	25	69	2	C0011053
Disease	Pancytopenia	BRCA2 FANCM	1.69e-03	26	69	2	C0030312
Disease	Miller Dieker syndrome	BRCA2 FANCM	2.10e-03	29	69	2	C0265219
Disease	FEV/FEC ratio	SCFD2 CACNA1D RBMS3 ARHGAP26 SYNE2 NEB FGD6 CCDC26 SPATA13	2.18e-03	1228	69	9	EFO_0004713

Protein segments in the cluster

Peptide	Gene	Start	Entry
IYMQKQGKNEHLAFN	ERI2	351	A8K979
LNQAFKEMHKNNKLA	CUL5	506	Q93034
QLQHENSILKGAQMK	DCTN1	1106	Q14203
KMLGLKSLQNNNQKQ	ALPK2	2126	Q86TB3
SLQKQMEHANQQTGF	GPS2	251	Q13227
NSTFCNKQNVHMLNK	ALMS1	3871	Q8TCU4
NKQNVHMLNKGIQAG	ALMS1	3876	Q8TCU4
MEPKNKGLKQQQQQH	C8orf34	316	Q49A92
QQQQHKKLLAAMLSQ	C8orf34	326	Q49A92
FHNQPQHTQMLLKKG	ANKRD55	171	Q3KP44
NEHSFNNFQMKIGLN	ADCY5	1166	O95622
RNHLKLPNNMNQTKS	ADAMTS12	1266	P58397
QQNLMKLQKGHVSLA	RANBP2	3041	P49792
QYQGQQMKALKHLRQ	RBM33	901	Q96EV2
LFSVINNSHNKKVQM	PDS5A	171	Q29RF7
SLKANGVQAQMAKQQ	RBMS3	121	Q6XE24
GHQLKKIMQTFVTQQ	PARP8	241	Q8N3A8
AQLKQFIQRHGMLKQ	GGNBP2	51	Q9H3C7
QGNAFSQMKKLQQLH	LRIG3	426	Q6UXM1
NKNKFIEQIQHLQSM	FANCM	1876	Q8IYD8
MQAEVTGKLKQHFNN	DCLK2	661	Q8N568
NMAKHFCKVLNQNQH	CD1A	156	P06126
VQKAIAHYDQQMGQK	GBP3	326	Q9H0R5
VQKAIAHYDQQMGQK	GBP5	326	Q96PP8
KQAGANQLMAFNHLI	PAX3	276	P23760
NQHAMVFFKKVSQNR	LCN2	136	P80188
LKSIMNKHQNLNSVD	ARHGAP29	86	Q52LW3
KKATMGQLQNKENNN	ARHGAP24	351	Q8N264
KLNMQNITHKENQNA	CCDC26	76	Q8TAB7
QHNQNMSGLEKVSKI	BRCA2	1931	P51587
GHLQNGKMQTKPNAN	FILIP1L	871	Q4L180
MKNHIQTSFQQLNGE	COL6A5	2041	A8TX70
ITHLNNNFMFGQKLN	HNRNPL	436	P14866
IQHLALGKNFNNMKS	CARMIL1	511	Q5VZK9
KAFSISQLQKNHDMN	CYP7B1	121	O75881
EMAGNRSQNIKHKQT	DNAJC9-AS1	106	A6NH13
NFHKEMSKLNQNLND	BIN1	251	O00499
QFHDLKQLFMSANNN	CGRRF1	221	Q99675
ALQQMRSKLNHNAAF	GFM1	186	Q96RP9
ANLNNANMSKAAHGK	CACNA1D	1756	Q01668
LLNTNGAQKKNLFQH	HSF2	201	Q03933
YQHSLNLLNKIQNMK	KBTBD12	11	Q3ZCT8
NAVLSKENHMQGKLN	KIF23	531	Q02241
TDKGQKKHFQQVFQM	RARS2	346	Q5T160
GLLQKNNHKMNKTSE	TRIM31	321	Q9BZY9
SLKLSNHQLKMQIQN	TMC3	706	Q7Z5M5
NQSQLAMNHLNGQKM	PTBP2	386	Q9UKA9
NNGLHNVEKMLQQKS	SYNE2	3696	Q8WXH0
ANVNGPKQLTHNLQM	RESF1	96	Q9HCM1
MFHKAQNAESSLQQK	RUFY1	466	Q96T51
LLNNLMTHQNVKLFK	GMCL2	236	Q8NEA9
NNHKQNLMTVANLGV	ARHGAP26	516	Q9UNA1
SIQAFKAHLEKMGNN	SIK3	631	Q9Y2K2
QLFKNNLKALMNHCG	SCFD2	391	Q8WU76
ANGVVKQLHFQEKQM	SEC23IP	611	Q9Y6Y8
KHKNNKVNVVLQNFM	SDAD1	151	Q9NVU7
VQDAHIQQMAKNKFN	CFAP210	431	Q0VFZ6
NINFIKMIHGTIKNQ	NCAPG2	236	Q86XI2
NQKKLAMLNAQKAGH	SPATA13	576	Q96N96
NFQDLKNQLKHMSVS	RPA2	226	P15927
NNMLTLNLVKQHTGK	THAP5	161	Q7Z6K1
HANDTMKQGDNFQKL	FGD6	1056	Q6ZV73
QNHTQGSKMQKNDFH	GPLD1	291	P80108
QHNGLKALMQFAVAQ	UBR1	1351	Q8IWV7
FMKKNQTLQNEILGH	SPTB	1516	P11277
LNLNGCNSLMKKLQH	USP38	476	Q8NB14
MGLKVIQQNVHKFLQ	MYH16	1	Q9H6N6
GKAFNQKGALQTHMI	ZNF236	231	Q9UL36
MNSGNRLLHKNFLKQ	TRANK1	341	O15050
IQKNAQALQQMLKHP	XRRA1	636	Q6P2D8
AQQGTLHEQKMKEAN	N4BP2	1656	Q86UW6
QKLNSVHANNKAFLQ	MYO7B	526	Q6PIF6
AQNNAKIMNEHLYKQ	NEB	1981	P20929